IPIC Submission on Bill S-228, An Act to Amend the Food and Drugs Act

IPIC's Position

IPIC views the changes as primarily a health policy matter and is not expressing an opinion on health policy. Rather, the purpose of this submission is to ensure that the Government is aware of how Bill S-228 would affect trademark rights for brand owners in Canada, impact consumer confusion, particularly related to possible counterfeit goods and affect Canada’s International Treaty obligations related to trademarks.